{
    "nctId": "NCT00555841",
    "briefTitle": "Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue",
    "officialTitle": "Safety and Efficacy of Oral Acetyl-l-carnitine (ALC) in Non-anemic Potentially Curable Breast Cancer Subjects Undergoing Adjuvant Radiation Therapy Who Have Moderate to Severe Fatigue",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 27,
    "primaryOutcomeMeasure": "Change of BFI as evaluated from Baseline to Final Visit",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Stage 0-III breast cancer in which adjuvant radiation is indicated;\n* Qualifying Brief Fatigue Inventory (BFI) score 6. -\n\nExclusion Criteria:\n\n* Medication to treat or manage fatigue and pain\n* Use of erythropoietin to control anemia\n* Clinical evidence of hypothyroidism or hyperthyroidism",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}